NHS National Framework for Ferric Carboxymaltose injection

NHS England

Key Details

Estimated Value

£38,217,000

Deadline

29 September 2026

Contract Period

Not specified

Procurement Method

open

Key requirements

Extracted from the notice; check the official documents.

Tender deadline: 29 Sept 2026, 13:00
Clarification questions by: 22 Sept 2026, 13:00
Estimated value: £38.2m£45.9m including VAT
Contract period: 1 Mar 2027 to 31 Jan 2029 (23 months)
Renewal / extension: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months
Procedure: Open procedure
Legal basis: Procurement Act 2023
Type: Framework agreement
Delivery location (NUTS/ITL): UKC (North East), UKD (North West), UKF (East Midlands), UKG (West Midlands), UKH (East of England), UKJ (South East) and 1 more
CPV code: 33600000 Pharmaceutical products
Suitability (buyer's flag): SME-suitable
Submission method: Electronic submission allowed

Award criteria

Price is not the only award criterion (price)100%

How to respond

The procurement documents are available for unrestricted and full direct access, free of charge at https://health-family.force.com/s/Welcome Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address

Description

Project title: NHS National Framework for Ferric Carboxymaltose Injection Offer reference number: CM/TNS/26/5743 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5743 Ferric Carboxymaltose Injection Lot 1 CESW 01/03/2027 to 31/01/2029 (23 months) Lot 2 NWLN 01/03/2027 to 31/05/2028 (15 months) Lot 3 LSNE 01/03/2027 to 31/05/2028 (15 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Suitability

SME Suitable

Previously won by

No award has been published for this tender. These are the latest award notices from NHS England for medical equipment & pharmaceuticals.

NHS National Framework for Tafamidis · published 2 Oct 2026

CiplaLarge
£941k · Awarded 29 Sept 2026 · Contract ends 31 May 2028 · Award notice ↗

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets · published 2 Sept 2026

Merck Sharpe & Dohme (UK) LimitedLarge, Orifarm UKSME, Unicorn Pharmaceuticals LtdSME, Lupin Healthcare (UK) LimitedSME
£8.5m (total, shared) · Awarded 12 Aug 2026 · Contract ends 31 Oct 2027

View Original Notice

Publication Info

Published28 August 2026

SourceFind a Tender